Teva Premium Swells on $250 Million Settlement: Israel Overnight

Wednesday, 22 February 2012 19:03 | Print | E-mail
Teva Pharmaceutical Industries Ltd. climbed in New York, pushing the premium over Israeli stock to a six-week high, on speculation the drugmaker is settling lawsuits alleging a treatment led patients to develop hepatitis C.

Let's Get Connected

TwitterFeed

TNCN Links

Other Sites of Interest !
advertisement

Subscribe

Receive occasional news and updates from Black-Americans.com by entering your name and email address below. This information is held in privacy and will not be shared with any third party. You may unsubscribe at any time.
First Name (*)
Last Name
Invalid Input
E-mail (*)
Invalid email address.
© 2012 BlackAmericans.com by IV Media LLC. All rights reserved.